8-K NKGen Biotech, Inc. 2026-09-02: filing_items
| Value | {"items": {"1.01": "Entry into a Material Definitive Agreement", "2.03": "Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant", "3.02": "Unregistered Sales of Equity Securities", "9.01": "Financial Statements and Exhibits"}, "value": "1.01,2.03,3.02,9.01"} |
|---|---|
| Period | (as of 2026-09-02) |
| Status | current |
| Entity | 8-K NKGen Biotech, Inc. 2026-09-02 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
Retrieved: 2026-09-02T23:18:49.387939+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/0658c257-72fb-4a3f-82a3-6dd6d1aeda3d
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
https://www.sec.gov/Archives/edgar/data/1845459/000121390026096778/0001213900-26-096778-index.htmRetrieved: 2026-09-02T23:18:49.387939+02:00
Raw response sha256:
cb14c96e1986419c07302f3a9a2b1842…Cite as: FACTANKER, https://factanker.com/fact/0658c257-72fb-4a3f-82a3-6dd6d1aeda3d
History
- no predecessors — first report